TapewireFind a company

person · Reporting owner

KLOSK STEVEN M

Disclosed activity across 3 companies

Tapewire entity
69466
SEC CIK
0001192621

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Bolt Projects Holdings, Inc.BSLK · Entity 65458DirectorNovember 25, 2024November 27, 2024
LISATA THERAPEUTICS, INC.LSTA · Entity 7814DirectorJanuary 09, 2026January 13, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Bolt Projects Holdings, Inc.

Report date November 25, 2024 · Filed November 27, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect72,500 Ending reported balance After 2024-11-25 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2024-11-25 · Grant · Acquired 22,500 · Balance 57,500

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.

F2: Represents an award of RSUs, which vests in three equal annual installments commencing on August 13, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Row 2 · 2024-11-25 · Grant · Acquired 15,000 · Balance 72,500

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.

F3: Represents an award of RSUs, which vests in full on the earlier to occur of (i) August 13, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service on the Board through the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.

F2: Represents an award of RSUs, which vests in three equal annual installments commencing on August 13, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F3: Represents an award of RSUs, which vests in full on the earlier to occur of (i) August 13, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service on the Board through the applicable vesting date.

LISATA THERAPEUTICS, INC.

Report date January 09, 2026 · Filed January 13, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect95,815 Reported balance After 2026-01-09 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-01-09 · Grant · Acquired 30,456 · Balance 95,815

F1: Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027.

F2: Includes 30,456 unvested restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027.

F2: Includes 30,456 unvested restricted stock units.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

CAMBREX CORP

Report date December 04, 2019 · Filed December 05, 2019

Section 16 reporting ended · disclosed 2019-12-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Ending reported balance After 2019-12-04 transaction · row 6
6 source rows · reconciled sequence

Row 1 · 2019-12-04 · Exercise / conversion · Acquired 50,000 · Balance 163,706

Row 2 · 2019-12-04 · Exercise / conversion · Acquired 50,000 · Balance 213,706

Row 3 · 2019-12-04 · Exercise / conversion · Acquired 38,000 · Balance 251,706

Row 4 · 2019-12-04 · Exercise / conversion · Acquired 30,000 · Balance 281,706

Row 5 · 2019-12-04 · Grant · Acquired 65,500 · Balance 347,206

F1: Each Company restricted stock unit subject to performance-vesting conditions (each, a "Company PSU") that was outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00, multiplied by the total number of shares of Company Common Stock subject to such Company PSU, with any performance-based vesting conditions deemed achieved at the greater of (x) target levels of performance and (y) actual levels of performance, without pro-ration.

Row 6 · 2019-12-04 · Sale · Disposed 347,206 · Balance 0

F2: Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. ("Parent"), Catalog Merger Sub ("Merger Sub"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the "Merger Agreement"). All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.36Direct0 Reported balance After 2019-12-04 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2019-12-04 · Exercise / conversion · Acquired 50,000 · Balance 0

F3: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.65Direct0 Reported balance After 2019-12-04 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2019-12-04 · Exercise / conversion · Acquired 50,000 · Balance 0

F3: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.64Direct0 Reported balance After 2019-12-04 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2019-12-04 · Exercise / conversion · Acquired 38,000 · Balance 0

F3: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.61Direct0 Reported balance After 2019-12-04 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2019-12-04 · Exercise / conversion · Acquired 30,000 · Balance 0

F3: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Filing footnotes · ownership attribution and instrument terms

F1: Each Company restricted stock unit subject to performance-vesting conditions (each, a "Company PSU") that was outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00, multiplied by the total number of shares of Company Common Stock subject to such Company PSU, with any performance-based vesting conditions deemed achieved at the greater of (x) target levels of performance and (y) actual levels of performance, without pro-ration.

F2: Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. ("Parent"), Catalog Merger Sub ("Merger Sub"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the "Merger Agreement"). All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement.

F3: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 09, 2026 Filed Jan 13, 2026 21:06 UTC LISATA THERAPEUTICS, INC. LSTA · Entity 7814 GrantCommon Stock 30,456 $0.00 $0.00
Disclosure

SEC source: 0001192621-26-000004 · wk-form4_1768338374.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,815

F1 · shares: Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027.

F2 · balance_after: Includes 30,456 unvested restricted stock units.

Read SEC document
January 09, 2025 Filed Jan 13, 2025 21:07 UTC LISATA THERAPEUTICS, INC. LSTA · Entity 7814 GrantCommon Stock 15,789 $0.00 $0.00
Disclosure

SEC source: 0001192621-25-000002 · wk-form4_1736802432.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,359

F1 · shares: Represents 15,789 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2026.

F2 · balance_after: Includes 15,789 unvested restricted stock units.

Read SEC document
November 25, 2024 Filed Nov 27, 2024 21:30 UTC Bolt Projects Holdings, Inc. BSLK · Entity 65458 GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-103492 · ownership.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,500

F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: Represents an award of RSUs, which vests in full on the earlier to occur of (i) August 13, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service on the Board through the applicable vesting date.

Read SEC document
November 25, 2024 Filed Nov 27, 2024 21:30 UTC Bolt Projects Holdings, Inc. BSLK · Entity 65458 GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-103492 · ownership.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: Represents an award of RSUs, which vests in three equal annual installments commencing on August 13, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
August 13, 2024 Filed Aug 15, 2024 20:41 UTC Bolt Projects Holdings, Inc. BSLK · Entity 65458 Exercise / conversionClass B Common Stock · Derivative 35,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-069731 · ownership.xml · derivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On August 13, 2024, pursuant to that certain Business Combination Agreement, dated as of October 4, 2023, as amended, by and among the Golden Arrow Merger Corp., Beam Merger Sub, Inc. ("Merger Sub") and Bolt Threads, Inc. ("Old Bolt Threads"), Merger Sub merged with and into Old Bolt Threads with Old Bolt Threads surviving as a wholly owned subsidiary of Golden Arrow Merger Corp., which changed its name to Bolt Projects Holdings, Inc. (the "Merger"). Upon the completion of the Merger, the shares of Class B Common Stock issued by Old Bolt Threads were automatically converted into shares of the Issuer's Common Stock on a one-to-one basis.

F1 · price: On August 13, 2024, pursuant to that certain Business Combination Agreement, dated as of October 4, 2023, as amended, by and among the Golden Arrow Merger Corp., Beam Merger Sub, Inc. ("Merger Sub") and Bolt Threads, Inc. ("Old Bolt Threads"), Merger Sub merged with and into Old Bolt Threads with Old Bolt Threads surviving as a wholly owned subsidiary of Golden Arrow Merger Corp., which changed its name to Bolt Projects Holdings, Inc. (the "Merger"). Upon the completion of the Merger, the shares of Class B Common Stock issued by Old Bolt Threads were automatically converted into shares of the Issuer's Common Stock on a one-to-one basis.

F1 · derivative.exercise_date: On August 13, 2024, pursuant to that certain Business Combination Agreement, dated as of October 4, 2023, as amended, by and among the Golden Arrow Merger Corp., Beam Merger Sub, Inc. ("Merger Sub") and Bolt Threads, Inc. ("Old Bolt Threads"), Merger Sub merged with and into Old Bolt Threads with Old Bolt Threads surviving as a wholly owned subsidiary of Golden Arrow Merger Corp., which changed its name to Bolt Projects Holdings, Inc. (the "Merger"). Upon the completion of the Merger, the shares of Class B Common Stock issued by Old Bolt Threads were automatically converted into shares of the Issuer's Common Stock on a one-to-one basis.

F1 · derivative.expiration_date: On August 13, 2024, pursuant to that certain Business Combination Agreement, dated as of October 4, 2023, as amended, by and among the Golden Arrow Merger Corp., Beam Merger Sub, Inc. ("Merger Sub") and Bolt Threads, Inc. ("Old Bolt Threads"), Merger Sub merged with and into Old Bolt Threads with Old Bolt Threads surviving as a wholly owned subsidiary of Golden Arrow Merger Corp., which changed its name to Bolt Projects Holdings, Inc. (the "Merger"). Upon the completion of the Merger, the shares of Class B Common Stock issued by Old Bolt Threads were automatically converted into shares of the Issuer's Common Stock on a one-to-one basis.

Read SEC document
August 13, 2024 Filed Aug 15, 2024 20:41 UTC Bolt Projects Holdings, Inc. BSLK · Entity 65458 Exercise / conversionCommon Stock 35,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-069731 · ownership.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On August 13, 2024, pursuant to that certain Business Combination Agreement, dated as of October 4, 2023, as amended, by and among the Golden Arrow Merger Corp., Beam Merger Sub, Inc. ("Merger Sub") and Bolt Threads, Inc. ("Old Bolt Threads"), Merger Sub merged with and into Old Bolt Threads with Old Bolt Threads surviving as a wholly owned subsidiary of Golden Arrow Merger Corp., which changed its name to Bolt Projects Holdings, Inc. (the "Merger"). Upon the completion of the Merger, the shares of Class B Common Stock issued by Old Bolt Threads were automatically converted into shares of the Issuer's Common Stock on a one-to-one basis.

F1 · price: On August 13, 2024, pursuant to that certain Business Combination Agreement, dated as of October 4, 2023, as amended, by and among the Golden Arrow Merger Corp., Beam Merger Sub, Inc. ("Merger Sub") and Bolt Threads, Inc. ("Old Bolt Threads"), Merger Sub merged with and into Old Bolt Threads with Old Bolt Threads surviving as a wholly owned subsidiary of Golden Arrow Merger Corp., which changed its name to Bolt Projects Holdings, Inc. (the "Merger"). Upon the completion of the Merger, the shares of Class B Common Stock issued by Old Bolt Threads were automatically converted into shares of the Issuer's Common Stock on a one-to-one basis.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 21:08 UTC LISATA THERAPEUTICS, INC. LSTA · Entity 7814 GrantCommon Stock 19,480 $0.00 $0.00
Disclosure

SEC source: 0001192621-24-000003 · wk-form4_1705007305.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,570

F1 · shares: Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025.

F2 · balance_after: Includes 19,480 unvested restricted stock units.

Read SEC document
January 09, 2023 Filed Jan 11, 2023 21:18 UTC LISATA THERAPEUTICS, INC. LSTA · Entity 7814 GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001192621-23-000002 · wf-form4_167347191558820.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,090

F1 · shares: Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024.

F2 · balance_after: Includes 24,362 unvested restricted stock units.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 21:12 UTC LISATA THERAPEUTICS, INC. CLBS · Entity 7814 GrantCommon Stock 65,430 $0.00 $0.00
Disclosure

SEC source: 0001192621-22-000002 · wf-form4_164202191754951.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,390

F1 · shares: Represents 65,430 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 10, 2023.

F2 · balance_after: Includes 103,165 unvested restricted stock units.

Read SEC document
January 11, 2021 Filed Jan 12, 2021 23:17 UTC LISATA THERAPEUTICS, INC. CLBS · Entity 7814 GrantCommon Stock 37,735 $0.00 $0.00
Disclosure

SEC source: 0001192621-21-000003 · wf-form4_161049344702656.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,960

F1 · shares: Represents 37,735 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 11, 2022.

F2 · balance_after: Includes 56,027 unvested restricted stock units.

Read SEC document
January 13, 2020 Filed Jan 14, 2020 21:14 UTC LISATA THERAPEUTICS, INC. CLBS · Entity 7814 GrantRestricted Stock Units 18,292 $3.28 $59,997.76
Disclosure

SEC source: 0001192621-20-000002 · wf-form4_157903647697000.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,225

F1 · shares: Represents 18,292 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 13, 2021.

F2 · balance_after: Includes 18,292 unvested restricted stock units.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $53.61 $0.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · derivative · entry 10

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

F3 · derivative.expiration_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 38,000 $0.00 Strike: $45.64 $0.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · derivative · entry 9

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

F3 · derivative.expiration_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $40.65 $0.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · derivative · entry 8

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

F3 · derivative.expiration_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $41.36 $0.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · derivative · entry 7

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

F3 · derivative.expiration_date: Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 347,206 $60.00 $20,832,360.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · nonDerivative · entry 6

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. ("Parent"), Catalog Merger Sub ("Merger Sub"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the "Merger Agreement"). All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 GrantCommon Stock 65,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · nonDerivative · entry 5

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,206

F1 · shares: Each Company restricted stock unit subject to performance-vesting conditions (each, a "Company PSU") that was outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00, multiplied by the total number of shares of Company Common Stock subject to such Company PSU, with any performance-based vesting conditions deemed achieved at the greater of (x) target levels of performance and (y) actual levels of performance, without pro-ration.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 30,000 $53.61 $1,608,150.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · nonDerivative · entry 4

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 38,000 $45.64 $1,734,320.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · nonDerivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 50,000 $40.65 $2,032,500.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2019 Filed Dec 5, 2019 13:40 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 50,000 $41.36 $2,068,000.00
Disclosure

SEC source: 0001209191-19-059247 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 17:05 UTC CAMBREX CORP CBM · Entity 153359 GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011177 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,706

F1 · shares: Pursuant to settlement of a performance share award.

Read SEC document
January 31, 2019 Filed Feb 4, 2019 18:33 UTC CAMBREX CORP CBM · Entity 153359 GrantCommon Stock 10,378 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-007018 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,706

F1 · security: Represents Restricted Stock Units

Read SEC document
January 14, 2019 Filed Jan 16, 2019 21:04 UTC LISATA THERAPEUTICS, INC. CLBS · Entity 7814 GrantRestricted Stock Units 12,121 $4.95 $59,998.95
Disclosure

SEC source: 0001192621-19-000013 · wf-form4_154767267234471.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,933

F1 · shares: Represents 12,121 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 14, 2020.

F2 · balance_after: Includes 12,121 unvested restricted stock units.

Read SEC document
January 08, 2019 Filed Jan 10, 2019 17:14 UTC LISATA THERAPEUTICS, INC. CLBS · Entity 7814 GrantCommon Stock 8,747 $0.00 $0.00
Disclosure

SEC source: 0001192621-19-000010 · wf-form4_154714047639341.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,812

F1 · shares: Represents 8,747 shares underlying restricted stock granted under the 2018 Equity Incentive Compensation Plan which were awarded on January 8, 2018 and which vested on January 8, 2019.

Read SEC document
October 24, 2018 Filed Oct 26, 2018 16:10 UTC CAMBREX CORP CBM · Entity 153359 GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $53.61 $0.00
Disclosure

SEC source: 0001209191-18-056290 · doc4.xml · derivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2025-10-24

F1 · derivative.exercise_date: The option representing a right to purchase 30,000 shares becomes exercisable in four equal installments beginning October 24, 2019, which is the first anniversary of the date on which the option was granted.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 17:21 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $17.81 $0.00
Disclosure

SEC source: 0001209191-18-056084 · doc4.xml · derivative · entry 4

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2021-10-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 17:21 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 3,195 $55.27 $176,593.40
Disclosure

SEC source: 0001209191-18-056084 · doc4.xml · nonDerivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,328

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.18 to $55.38 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 17:21 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 16,805 $54.67 $918,660.45
Disclosure

SEC source: 0001209191-18-056084 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,523

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.16 to $55.10 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 17:21 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 20,000 $17.81 $356,200.00
Disclosure

SEC source: 0001209191-18-056084 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document
September 04, 2018 Filed Sep 5, 2018 16:24 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 55,000 $0.00 Strike: $17.81 $0.00
Disclosure

SEC source: 0001209191-18-049558 · doc4.xml · derivative · entry 4

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 55,000 shares

Expires 2021-10-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.

Read SEC document
September 04, 2018 Filed Sep 5, 2018 16:24 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 25,809 $66.83 $1,724,815.47
Disclosure

SEC source: 0001209191-18-049558 · doc4.xml · nonDerivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,328

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.50 to $67.30 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.

Read SEC document
September 04, 2018 Filed Sep 5, 2018 16:24 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 29,191 $65.84 $1,921,935.44
Disclosure

SEC source: 0001209191-18-049558 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,137

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.425 to $66.35 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.

Read SEC document
September 04, 2018 Filed Sep 5, 2018 16:24 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 55,000 $17.81 $979,550.00
Disclosure

SEC source: 0001209191-18-049558 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
August 06, 2018 Filed Aug 7, 2018 17:56 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 26,401 $63.23 $1,669,335.23
Disclosure

SEC source: 0001209191-18-045748 · doc4.xml · nonDerivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,328

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $63.65 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.

Read SEC document
August 06, 2018 Filed Aug 7, 2018 17:56 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 53,599 $62.07 $3,326,889.93
Disclosure

SEC source: 0001209191-18-045748 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,729

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.65 to $62.65 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.

Read SEC document
August 01, 2018 Filed Aug 2, 2018 16:34 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $17.81 $0.00
Disclosure

SEC source: 0001209191-18-044967 · doc4.xml · derivative · entry 6

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 5,000 shares

Expires 2021-10-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 22,2015, which was the first anniversary of the date on which the option was granted.

Read SEC document
August 01, 2018 Filed Aug 2, 2018 16:34 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $16.91 $0.00
Disclosure

SEC source: 0001209191-18-044967 · doc4.xml · derivative · entry 5

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2020-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 28,2014, which was the first anniversary of the date on which the option was granted.

Read SEC document
August 01, 2018 Filed Aug 2, 2018 16:34 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 22,782 $62.78 $1,430,222.07
Disclosure

SEC source: 0001209191-18-044967 · doc4.xml · nonDerivative · entry 4

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,328

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $62.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.

Read SEC document
August 01, 2018 Filed Aug 2, 2018 16:34 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 32,218 $62.23 $2,005,026.02
Disclosure

SEC source: 0001209191-18-044967 · doc4.xml · nonDerivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,110

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.70 to $62.675 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.

Read SEC document
August 01, 2018 Filed Aug 2, 2018 16:34 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 5,000 $17.81 $89,050.00
Disclosure

SEC source: 0001209191-18-044967 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document
August 01, 2018 Filed Aug 2, 2018 16:34 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 50,000 $16.91 $845,250.00
Disclosure

SEC source: 0001209191-18-044967 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934

Read SEC document
July 02, 2018 Filed Jul 3, 2018 16:20 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $16.91 $0.00
Disclosure

SEC source: 0001209191-18-041045 · doc4.xml · derivative · entry 6

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 30,000 shares

Expires 2020-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 28,2014, which was the first anniversary of the date on which the option was granted.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 16:20 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $12.46 $0.00
Disclosure

SEC source: 0001209191-18-041045 · doc4.xml · derivative · entry 5

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2019-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 24, 2013, which was the first anniversary of the date on which the option was granted.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 16:20 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 24,358 $52.08 $1,268,564.64
Disclosure

SEC source: 0001209191-18-041045 · doc4.xml · nonDerivative · entry 4

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,328

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.35 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 16:20 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 30,642 $51.45 $1,576,530.90
Disclosure

SEC source: 0001209191-18-041045 · doc4.xml · nonDerivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,686

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.975 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 16:20 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 30,000 $16.91 $507,150.00
Disclosure

SEC source: 0001209191-18-041045 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
July 02, 2018 Filed Jul 3, 2018 16:20 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionCommon Stock 25,000 $12.46 $311,500.00
Disclosure

SEC source: 0001209191-18-041045 · doc4.xml · nonDerivative · entry 1

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 11, 2018 Filed Jun 12, 2018 21:13 UTC CAMBREX CORP CBM · Entity 153359 Exercise / conversionStock Option (right to buy) · Derivative 55,000 $0.00 Strike: $12.46 $0.00
Disclosure

SEC source: 0001209191-18-037357 · doc4.xml · derivative · entry 3

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 55,000 shares

Expires 2019-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 24, 2013 which was the first anniversary of the date on which the option was granted.

Read SEC document
June 11, 2018 Filed Jun 12, 2018 21:13 UTC CAMBREX CORP CBM · Entity 153359 SaleCommon Stock 55,000 $45.64 $2,510,244.00
Disclosure

SEC source: 0001209191-18-037357 · doc4.xml · nonDerivative · entry 2

KLOSK STEVEN M · CIK 0001192621 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,328

F1 · shares: The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.40 to $45.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.